Chikungunya virus-like particle vaccine

Pharmacology, Toxicology and Pharmaceutical Science

• Virus Like Particle Vaccine 100%
• Chikungunya Virus 100%
• Alphavirus 61%
• Baculoviridae 53%
• Salmonid 46%
• Virus Like Agent 46%
• Chikungunya 26%
• Neutralizing Antibody 23%
• Diseases 19%
• Immunogenicity 15%
• Vaccine Development 15%
• Glycoprotein E2 15%
• Polyprotein 15%
• Furin 15%
• DNA Immunization 15%
• Mouse Model 11%
• Virus Vaccine 11%
• Leporidae 7%
• Arthropod 7%
• Receptor 7%
• Antivirus Agent 7%
• Aedes albopictus 7%
• Togaviridae 7%
• Mosquito Vector 7%
• Structural Protein 7%
• Polyhedrin 7%
• Recombinant Protein 7%
• Virus Glycoprotein 7%
• Glycoprotein E1 7%
• Plasmid DNA 7%
• Signal Peptide 7%
• Arbovirus 3%
• Adjuvant 3%
• Immunoglobulin G1 3%

Immunology and Microbiology

• Virus Like Particle Vaccine 100%
• Chikungunya Virus 100%
• Alphavirus 51%
• Baculoviridae 45%
• Virus-Like Particle 38%
• Salmonid 38%
• Insect Cell 22%
• Neutralizing Antibody 19%
• Viral Disease 16%
• Gene Expression System 16%
• Wild Type 16%
• Immunogenicity 12%
• Glycoprotein 12%
• Promoter Region 12%
• Morphology 12%
• DNA Immunization 12%
• Large Scale Production 9%
• Mouse Model 9%
• Virus Vaccine 9%
• Innate Immune System 6%
• Plasmid 6%
• High Fever 6%
• Protein Subunit Vaccine 6%
• Aedes albopictus 6%
• Togaviridae 6%
• Polyhedrin 6%
• Carboxy Terminal Sequence 6%
• Glycosylation 6%
• Virus Attenuation 6%
• Leporidae 6%
• Precursor 6%
• Capsid 6%
• Genetic Transfection 6%
• Antibody Titer 6%
• Virus Inactivation 6%
• Arthropod 6%
• Vertebral Column 6%
• Peptides 6%
• Structural Protein 6%
• Humoral Immunity 3%
• Adjuvant 3%
• Arbovirus 3%
• Adoptive Immunity 3%
• Antibody Response 3%
• Downstream Processing 3%
• Immunoglobulin G1 3%